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Abstract
Background: Aloe’s reported bioactivities (anticancer, anti-inflammatory and wound healing) suggest they might
inhibit a subgroup of matrix metalloproteinases (MMPs) called gelatinases (MMP-2 and MMP-9). The goal of the
present study was to compare the MMP inhibitory potential of two Aloe species, A. vera and A. arborescens.
Methods: Different types of extraction were tested and specific bioactive compounds were quantified. Cancer cell
invasion inhibitory activities were measured in vitro using the wound healing assay in human colon cancer cells
(HT29). Effects on gelatinase activities were further assessed by dye-quenched gelatin and gelatin zymography.
Results: Different types of extraction yielded significantly different levels of bioactivities and of bioactive
compounds, which might be due to a greater amount of extractable bioactive compounds such as anthraquinones.
Both A. arborescens and A. vera have potential as inhibitory agents in cancer cell proliferation via MMP-9 and MMP-2
enzymatic activity inhibition, being able to reduce colon cancer cell proliferation and migration but A. arborescens
showed to be a more effective inhibitor of cancer cell migration than A. vera.
Conclusion: This work opens novel perspectives on the mode of action of Aloe species in cancer cell migration
and may provide clues as to why there are so many conflicting results on Aloe’s activities.
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Background
The plant genus Aloe is largely known for its medicinal
purposes for many centuries. Its uses are mentioned to
as early as in Egyptian papyri, the Dioscorides’ Materia
Medica (~ 60 CE) or the Garcia de Orta’s Colloquies
(1563 CE in Goa) [1, 2]. Presently, Aloe species account
among the most economically important medicinal
plants and are commonly used for several ailments,
namely anti-inflammatory, antiulcer, and immunomodu-
latory to antimicrobial activities [3–6]. Several studies
have revealed the effectiveness of Aloe plants towards
various types of cancer, like colon, duodenal, intestinal,
lung, kidney pancreatic, liver, and skin, and these works
have been confirmed through numerous in vitro and in
vivo experiments [7, 8].
Nonetheless, antagonist results arise frequently: whilst
many papers described its anticancer properties [7, 8],
others surprisingly claim A. vera is indeed carcinogenic
over a specific dose [9] or alert that specific compounds
present in Aloe may be highly toxic if not taken under
caution [10]. One reason for this could be the overall
misidentification of the Aloe genus species, since current
research supports that there are Aloe species that have
more potent bioactivities than Aloe vera [11].
Today, A. barbadensis Mill. (A. vera) is incontestably
the most common species of Aloe used worldwide, often
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incorrectly mentioned to as the one with the highest
bioactivities in anecdotal reports [12, 13]. Yet, there are
about 500 Aloe species documented, from which just a
small fraction has reported ethnomedicinal uses [11].
Additionally, the phenotype similarities among species
are enormously high, inducing people to use frequently
the wrong species. Hence, because of its huge medicinal,
cosmetic and other demands there is a high possibility
that some species may often be mistakenly identified for
different medicinal usages [14]. On the other hand, the
use of single specific phytochemical derived from Aloe
instead of the crude and/or standardized extracts could
affect the overall bioactivities since it has been shown
that many components in Aloe act synergistically with
the remaining constituents in the plant [14]. In this
sense, it also noteworthy to state that there is an overall
lack of consistency regarding the type of extractions to
use. Several works report the use of aqueous extracts
[15] whilst others mention to use alcoholic or organic
solvents like acetone or methanol [16, 17]. Taking into
account that Aloe’s main phytochemical groups vary
from phenols to proteins, carbohydrates, vitamins and
organic and inorganic compounds [3], it is relevant to
explore different types of extractions.
Another important factor to consider is the method of
functioning of this genus’ bioactivities. Currently, a par-
ticular group of matrix metalloproteinases (MMPs)
named gelatinases (MMP-2 and MMP-9) is greatly asso-
ciated to cancer invasion through degradation of the cel-
lular matrix, and the consequent release of cancer cells
via proteolysis [18–20]. Since MMP-9 activities have also
been closely associated to inflammation and delay in
wound closure [21, 22] it is very likely that Aloe com-
pounds could target these gelatinases. Indeed, concern-
ing inflammation, Aloe vera extracts are recognized to
down regulate metalloproteinase expression, precisely
MMP-9, which contributes to the extracellular matrix
degradation when recruited by cytokines to inflamma-
tion sites [23]. Hence, it is quite probable that Aloe spe-
cies might inhibit enzymatic activity of MMP-2 (72 kDa)
and MMP-9 (92 kDa) in cancer-related situations. How-
ever, to our knowledge there has been no link estab-
lished between gelatinase activity inhibition induced by
Aloe plants and cancer.
These studies can be valuable to confirm the real effect
of Aloe species on cancer and eventually provide the
identification of innovative anticancer approaches. Fur-
thermore, the analysis of gelatinase activity inhibition by
A. vera extracts may also constitute a novel perspective,
which can help to comprehend the mechanisms of ac-
tion of the plants from this genus. With that in mind,
we set out to evaluate the content of several classes of
potentially bioactive compounds, using different extrac-
tion procedures and their impact on the growth and
migration of colon adenocarcinoma cells, as well as their
effect on MMP-9 and MMP-2 activities.
Methods
Species selected and collection of plant samples
Leaves of A. vera and A. arborescens were collected from the
existing Collection of Aloe genus specimen of Parque Botâ-
nico da Tapada da Ajuda (member of the Botanic Gardens
Conservation International – BGCI), Instituto Superior de
Agronomia, University of Lisbon (ISA/UL), Portugal. The
species were kindly identified by Dr. Nuno Costa, Botanist,
and are still alive in Parque Botânico da Tapada da Ajuda,
ISA/UL, Portugal. All selected individuals had several years
of existence and were not in the flowering season. Leaf sam-
ples were collected from at least three different plants.
Preparation of the leaf extracts
Fresh leaves were washed with distilled water and
chopped into small fragments of approximately 20 g
each. Three different extraction methods were per-
formed using different solvents at a ratio of 1:5 (w/v): 1)
100% (v/v) methanol, 2) 50% (v/v) methanol, and 3) 100
mM Tris-HCl buffer, pH 7.0. All extractions were per-
formed by grinding a sample of 20 g with the respective
solvent using an ULTRA-TURRAX T25 (IKA®Labor-
technik) grinder, followed by agitation for 4 h at 4 °C.
Both extracts containing methanol were evaporated in a
bath at 60 °C (Kottermann) whereas the aqueous extracts
were desalted through filtration using 3 kDa membrane
centricons and centrifuged at 2000 g. All extracts were
then lyophilized (Edwards Modulyo EF4) for 24 h and
the obtained powder was weighted and stored at − 20 °C.
Quantification of potentially bioactive compounds
Proteins
Protein quantification was performed using the standard
Bradford method as described by Bradford [24]. The
samples were read in a spectrophotometer Syenery HT,
Bio-TEK at 595 nm and bovine serum albumin was used
as standard. All samples used in protein quantification
were treated with PVPP to eliminate the phenolic com-
pounds that could interfere with the extraction of sol-
uble proteins [25].
Phenolic compounds
The phenolic compounds were quantified using the
Folin-Ciocalteau reagent using gallic acid as standard.
The lyophilized powder (corresponding to 20 g of fresh
leaves) was treated with 10 μL of 70% (v/v) acetone, 10
μL of 0.5% (v/v) acetic acid and 80 μL of 7% (w/v) so-
dium carbonate. Subsequently, a volume of 100 μL of
Folin-Ciocalteau was added to the solution and the mix-
ture was vortexed. The solution of 200 μL was incubated
for 8 min at room temperature and the absorbance was
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read in a Syenery HT Bio-TEK spectrophotometer at
765 nm [26].
Anthraquinone
To 300 μL of the previous extracts, 300 μL of pure ben-
zene were added and the resulting solution incubated with
agitation at 0 °C bath for 30 min. It was then centrifuged
at 4.500 g for 20 min at 4 °C in a Beckman J2-21M/E cen-
trifuge. To the recovered supernatant 500 μL of 10% (v/v)
ammonia solution were added and the absorbance read at
515 nm using Aloe blue curacao aloin as a standard [27].
Total carbohydrates
Sugar quantification was performed utilizing the phenol/
sulfuric acid method and mannose was used as the stand-
ard. To the previous extracts a 4% (v/v) phenol solution
was added in a proportion of 1:5 and then incubated 5
min at room temperature. Afterwards, a 1:40 proportion
of sulfuric acid was added and the absorbance read at 492
nm in the equipment mentioned above [28].
In vitro colon cancer cell assays
The human colon adenocarcinoma cell line HT29 (ECAC
C 85061109) was purchased from the European Collection
of Authenticated Cell Cultures, UK, and was used
throughout this work. HT29 cell lines were maintained in
RPMI medium supplemented with 10% (w/v) of heat-
inactivated fetal bovine serum and 200mM glutamine,
2 × 104 UI/mL penicillin and 20mg/mL streptomycin at
37 °C, in a humidified atmosphere of 5% (v/v) CO2.
Cell proliferation assay
HT29 cultured cells were seeded on 96-well plates (2 ×
104 cells/well) and Aloe leaf extracts were added to the
growth media to obtain different final concentrations,
and incubated for 24 h. After each treatment, the extra-
cellular media was collected, and the wells were washed
with PBS to remove unattached cells. Cell proliferation
and viability was determined using the standard 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay as described by Carmichael et al. [29].
Cell migration assay
For cell migration analysis, the wound healing assay was
performed. HT29 cells (5 × 105 cells/well) were seeded in
6-well plates and allowed to reach to 80% confluence.
Wounds were performed by making a scratch across the
cell monolayer to create an open gap, mimicking a
wound. Cells were then washed twice with PBS to re-
move floating debris. Each well was subsequently filled
with fresh media containing the samples under study, in
a concentration of 100 μg/mL and allowed to grow for
48 h. The invaded area after 48 h was calculated in each
treatment and compared to the initial area at 0 h, to
determine the area covered by migrating cells into the
denuded zone at the beginning of treatment. This com-
parison allowed us to assess the inhibitory effect (if any)
exerted by each protein fraction on the HT29 cell mi-
grating capacity.
MMP-9 and MMP-2 catalytic activities
Gelatinolytic activity with commercial MMPs
The fluorogenic substrate dye-quenched (DQ)-gelatin was
purchased from Invitrogen (Carlsbad, CA, USA) and dis-
solved in water at 1mg/mL. All solutions and dilutions
were prepared in assay-buffer (50mM Tris-HCl buffer, pH
7.6, containing 150mM NaCl, 5mM CaCl2 and 0.01% v/v
Tween 20). A 96-well micro-assay plate (chimney, 96-well,
black) was used. Each well was loaded with 0.1mM (for a
final volume of 200 μL) MMP-9 (Sigma), to which 100 μg/
mL protein of total Aloe extract (for a final volume of
200 μL) was added, and the plate was incubated for 1 h at
37 °C. Subsequently, DQ-gelatin (at a final concentration of
2.5 μg/mL) was added to each well and the plate was incu-
bated again, for 1 h. Fluorescence levels were measured (ex.
485 nm/em. 530 nm). In each experiment, both positive (no
sample) and negative (no enzyme) controls were included
for all samples, to correct for possible proteolytic activities
present in the Aloe extracts. All data were corrected by sub-
traction of their corresponding negative controls.
Gelatinolytic activity with HT29 cell culture extracellular
media
The same method described above was used, with some
alterations. Roughly, each well was loaded with 100 μL of
extracellular HT29 media (containing MMP-9 and MMP-
2) after exposure to the Aloe extracts. Subsequently, DQ-
gelatin (at a final concentration of 2.5 μg/mL) was added
to each well (for a final volume of 200 μL) and the plate
was incubated again, for 1 h. Fluorescence levels were
measured (ex. 485 nm/em. 530 nm).
Gelatin zymography
To determine metalloproteinase activities in HT29 can-
cer cell culture supernatants, a gelatin-zymography was
performed according to standard methods adapted by
Lima et al. [30]. Cell culture supernatants were treated
with 62.6 mM Tris-HCl buffer, pH 6.8, containing 2%
w/v SDS, 10% v/v glycerol and 0.01% w/v bromophenol
blue and separated in SDS-polyacrylamide gels (12.5%
w/v acrylamide) with 1% (w/v) gelatin. After electro-
phoresis, gels were washed three times in 2.5% (v/v) Tri-
ton X-100 for 90 min each and incubated at 37 °C with
developing buffer for 24 h. After staining with Coomas-
sie Brilliant Blue G-250, the white bands visible marked
the gelatinase activity of each proteinase. Protein band
intensities were determined by densitometry as de-
scribed earlier [30].
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Statistical analysis
All experiments were performed in triplicate, in at least
three independent times and the data are expressed as the
mean ± standard deviation (SD). SigmaPlot software (ver-
sion 12.5) was used for comparing different treatments,
using one-way and two-way analysis of variance
(ANOVA). Tukey’s test was used to compare differences
between groups and the statistical differences with p value
less than 0.05 were considered statistically significant.
Results
The amount of bioactive compounds extracted from A.
arborescens and A. vera is influenced by the species and
by the extraction procedure
The amounts of the different classes of bioactive com-
pounds in both Aloe species are present in Fig. 1. When
comparing A. vera and A. arborescens we can easily
identify differences between species regarding both the
extraction methods for each component and the amount
of each component per amount of fresh weight. Results
presented in Fig. 1 (a) corroborate the low amount of
proteins present in both species, which were overall less
than 0.1% (w/v) of fresh weight. Nonetheless, protein
amounts and distribution varied significantly between
both species.
Whilst the amount of Tris-HCl-soluble protein was
significantly higher (p < 0.05) in A. arborescens than in
A. vera, A. vera presented the higher amounts of
methanol-soluble proteins than A. arborescens (p < 0.05).
Phenolic compounds were already described as the
second major class of compounds found in A. vera [31],
second only to polysaccharides (Fig. 1 (b)). Regarding
the results in Fig. 1 (b), corresponding to total phenols
present per extraction, it is clear that the extraction with
50% (v/v) methanol yields higher amounts of total phen-
olic in A. vera extraction (26.19 μg/g), whereas for A.
Fig. 1 Quantitative characterization of A. vera and A. arborescens considering the main phytochemical groups defined by Hamman [3]. Each
extraction was performed with 20 g of fresh Aloe leaves for each of the three solvents: 100 mM Tris-HCl buffer, 50% (v/v) methanol and 100% (v/
v) methanol. a Protein quantification using the Bradford method described by Bradford (1976). All samples were treated with
Polyvinylpolypyrrolidone (PVPP) to eliminate the phenolic compounds that could interfere with the extraction of soluble proteins. b Phenolic
compounds quantification with the Folin-Ciocalteau reagent and using gallic acid as standard. c Total carbohydrates quantification using phenol/
sulfuric acid method and mannose as the standard. d Specific anthraquinone quantification (phenol component) using benzene, ammonia
solution and Aloe blue curacao aloin. * p < 0.05; **p < 0.001 when compared between extracts of the same species; # p < 0.05; ## p < 0.001 the
same extract when compared between species
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arborescens the extraction with 100% (v/v) methanol
yielded the highest amounts (16.48 μg/g), in a significant
manner (p < 0.05). Albeit in Fig. 1 (b) A. vera presented
more phenolic compounds (p < 0.05) when compared to
A. arborescens, when evaluating the specific group of an-
thraquinones (Fig. 1 (d)), A. arborescens had a significant
higher content in the methanolic extractions.
Finally, regarding the composition in total polysaccharides
between the two species (Fig. 1 (c)), the extraction with 50%
(v/v) methanol presented a significantly higher yield than the
other two extractions (p < 0.001). For example, A. vera con-
tains 7.72 ng/g against 0.25 ng/g for 100mM Tris-HCl buffer
and 0.14 ng/g for 100% (v/v) methanol.
Different Aloe extraction procedures exert different
effects on cancer cell migration
To test and compare the anticancer and MMP-9 inhibi-
tory potential of two extracts from A. vera and A. arbor-
escens, a colon cancer cell line HT29 was selected, using
the standard cell migration assays, and results are
expressed in Fig. 2.
Since distinct extraction procedures seem to provide dif-
ferent quantities of various compounds and differ between
Aloe species, we aimed to select the best extraction
method for the HT29 cell assays, using buffer-soluble and
methanolic extractions. The results expressed in Fig. 2 in-
dicate that buffer-soluble extractions did not show any
significant reduction in cell migration when compared to
controls (p > 0.05), in contrast to the methanolic extrac-
tions where an overall reduction in cell migration was ob-
tained by both species extracts. Concerning A.
arborescens, both methanolic extractions led a significant
reduction (p < 0.001) of about 80% in cell migration. In
the case of A. vera the best results were obtained for 50%
(v/v) methanolic extracts when compared to the 100% (v/
v) methanolic extract (p < 0.05). As there was no differ-
ence for A. arborescens and as it provided the best results
for A. vera, the 50% (v/v) methanolic extractions were se-
lected for the remaining cancer cell assays.
Aloe extracts influence HT29 colon cancer cell
proliferation in a dose-dependent manner
To investigate whether the effect of the Aloe extracts
inhibited colon cancer cell growth, we tested different
concentrations of the selected 50% (v/v) methanolic Aloe
extracts. Figure 3 shows the proportion of HT29 living
cells after growth in the presence of 10, 25 and 50 μg dry
weight/mL Aloe extracts, obtained after staining with
MTT (which can only be metabolized by living cells).
The results indicate that a 2-day exposure to the 50% (v/
v) methanolic extract from both studied Aloe species did
induce a significant reduction (p > 0.001) in cancer cell
growth when compared to controls. Additionally, this re-
duction was highly dose-dependent, with higher concen-
trations leading a significantly higher inhibition than the
previous (p < 0.05). Remarkably, even though it has been
suggested that A. vera is the Aloe species with the lowest
toxicity, our results indicate that there were no signifi-
cant differences (p < 0.001) between A. arborescens and
A. vera extracts for all the tested concentrations. Being
dose-dependent, the results point to an EC50 around
25 μg dry weight/mL for the 50% (v/v) methanolic ex-
tracts (A. vera: 24.27 μg and A. arborescens: 26.8 μg).
Fig. 2 Percentage of cell migration after a 48 h period of HT29 cell exposure to A. arborescens and A. vera different extracts. Extracts were
prepared with 100mM Tris-HCl buffer, 50% or 100% (v/v) methanol (MetOH). * p < 0.05; **p < 0.001 when compared to controls on the same
extraction; # p < 0.05; ## p < 0.001 when compared between the same species on the same type of extraction
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The results for the minimal inhibitory concentrations
(MIC), which in this work was determined as the lowest
concentration which prevented 10% growth inhibition
are presented in Table 1. MIC results point to much
lower inhibitory concentrations, showing stronger inhib-
ition for A. arborescens, with a MIC of 3.12 μg dry
weight/mL, which is approximately half the MIC deter-
mined for A. vera.
EC50 Aloe extracts reduce colon cancer cell migration
Concerning the wound healing assay, we set out to
characterize the migratory response of HT29 cells when
exposed to the 50% (v/v) methanolic extractions of A.
arborescens and A. vera. Since the EC50 concentration
was around 25 μg/mL, this concentration was selected
for the wound healing assays and the results are shown
in Fig. 4. The percentage of wound closure of cells ex-
posed to the Aloe extracts was compared to a positive
control (deoxycycline at a concentration of 40 μg/mL),
which presented a gap above 50% after 48 h.
Results indicated that all treatments induce high signifi-
cant differences (p < 0.001) when compared to control.
Contrasting to the cell proliferation assays, significant dif-
ferences were observed between A. arborescens and A.
vera extracts (p < 0.05). While A. arborescens exhibited a
wound closure of 19%, A. vera was less effective in inhibit-
ing cell invasiveness, with 37% of wound closure, which
was significantly higher than deoxycycline. Under these
conditions, A. arborescens yielded a cell viability of 45%
and A. vera of 35% (data not shown).
Aloe extracts inhibit MMP-9 and MMP-2
MMPs have been implicated in the migratory capacity of
cancer cells due to its ability to degrade the extracellular
matrix. Under this context, it was also our goal to test
the activities of MMP-2 and MMP-9 in the extracellular
media of the HT29 cells. Figure 5 shows the specific
MMP-9 and MMP-2 gelatinolytic activity present in the
extracellular media of HT29 cells, using zymography. In
the gelatin zymography, white bands are indicative of
non-inhibited MMP gelatinolytic activity, including that
of the pro-enzyme and its active form. Concerning the
MMPs, they are generally synthesized as zymogens (pro-
MMPs), with their catalytic activity blocked by a cysteine
switch and are only activated by its removal, through
limited proteolysis. In the zymography assay, the pro-
gelatinases similarly become active because they are
denaturated by the SDS, therefore exposing the catalytic
site (hence the slightly higher mass of the pro-enzymes
in the zymography, which still maintain the short amino
acid sequence of the cysteine switch). Consequently,
there are two white bands for each MMP, as observed in
the controls in Fig. 5 (a): gelatinase A or MMP-2 has a
72 kDa molecular mass, whereas gelatinase B or MMP-9
has 92 kDa.
When analyzing the lanes of the extracellular media
exposed to the Aloe extracts, we can perceive that, after
exposure to the Aloe extracts, MMP-9 and MMP-2 en-
zymatic activities were inhibited, in both forms, pro-
Fig. 3 HT29 cell proliferation assay. Cells were exposed for 48 h to A. arborescens or A. vera extracts prepared with 50% (v/v) MetOH (methanol).
Cell growth was obtained by the standard MTT assay. Results are expressed as the mean of at least three replicate experiments ±SD.*p < 0.05
between concentrations
Table 1 Minimal inhibitory concentrations for cell growth when
HT29 cells were exposed to different concentrations of A. vera
and A. arborescens extracts prepared with 50% (v/v) MetOH
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enzyme and active form, with a more pronounced in-
hibitory specificity of both Aloe species towards MMP-9.
In order to comprehend if the observed inhibitory activ-
ities were due to direct binding of Aloe extract compo-
nents to MMP-9, we further tested their inhibitory
activity concerning this enzyme. Figure 5 (c) illustrates
the commercial MMP-9 (Sigma) activities in the pres-
ence of A. vera or A. arborescens extracts, expressed in
percentage of controls. As observed in Fig. 5 (c), both
Aloe extracts reduced MMP-9 activity directly, but this
inhibition was higher for A. arborescens (p < 0.001) than
for A. vera (p < 0.05).
Discussion
Evidence has shown that certain bioactive phytochemi-
cals are often present in more than one Aloe species
[33], an observation that inevitably supports the species-
substitution hypothesis in traditional medicine. Among
the hundreds of identified Aloe species, there are two
which stand out as the most common in European
countries, A. vera, because of its huge popularity, and A.
arborescens, because it is well adapted to the European
climates and is widely spread across the public gardens
as an ornamental plant. Although there are many differ-
ences between both species, such as morphological fea-
tures, flower color, sap color, smell and other
histological features, both species are often mistaken, as
many media and anecdotal reports show. Although there
are several articles highlighting the phytochemical com-
position of A. vera, much less is known about other spe-
cies, like A. arborescens. In this work, we aimed to
compare the potential anti-cancer and MMP-9 inhibi-
tory activities between these two well-known Aloe spe-
cies, A. vera and A. arborescens.
The literature describes several compounds in A. vera
[33] which can be responsible for the various pharmaco-
logical activities previously described. The main phyto-
chemical groups present in A. vera have been described
as phenolic compounds (anthraquinones, anthrones),
carbohydrates and proteins [3, 16, 33–36]. These differ-
ent metabolites or phytochemicals may act individually,
additively or in synergy to improve the plant’s health
and its chances of survival in a given environment. Fur-
thermore, it has been suggested that these combined ac-
tions of the phytochemicals usually tend to increase the
bioactivity of the main medicinal constituents by influ-
encing its assimilation in the body [15, 37]. Because of
that, in this work, we not only aimed to compare the
amounts of the potentially bioactive compounds in the
two selected species, but we also wanted to select the
best extraction procedure, that would allow the highest
yield in these compounds. Therefore, we set out to
Fig. 4 Wound healing assay on HT29 cells exposed to A. arborescens or A. vera. Extracts were prepared with 50% (v/v) MetOH (methanol). a
Examples depicting cells at time 0 h and after 48 h of exposure. b Wound closure after a 48 h period cell exposure to A. arborescens or A. vera
extractions with 50% (v/v) methanol. Doxycycline at a concentration of 40 μg/mL was used as a positive control for metalloproteinase inhibition
[32]. *p < 0.05; **p < 0.001 when compared to positive controls; # p < 0.05; ## p < 0.001 when compared to doxycycline
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quantify the major classes of bioactive compounds: pro-
teins, total phenolic compounds and specifically anthra-
quinones, and total polysaccharides. When considering
the whole leaf as an organ for phytochemical extraction,
the possibility to combine several components has been
suggested to potentiate its therapeutic activity [15, 37].
However, the choice of the extraction method by which
the compounds are obtained was shown to be essential.
Results here presented show that the extraction method
not only influences the amount of bioactive component
extracted but it also differs among species. Whilst for A.
vera, for all compound’s classes except the proteins, the
majority of the compounds were better extracted with
50% (v/v) methanol (phenolics and polysaccharides, with
p < 0.05) for A. arborescens the highest yields were ob-
tained in the 100% (v/v) methanol extraction. This sug-
gests the presence of different compounds but more
importantly, it arises the question of whether most litera-
ture using non-aqueous polar and non-polar solvents such
as ethanol, acetone etc. are using the correct extractions
to yield the better bioactivities with A. vera. This could be
of significant importance since it is well-known that poly-
saccharides like acemannan were found responsible for
the stimulation of the immune response in cancer scenar-
ios, contributing to tumor weight reduction and the im-
provement of chemotherapy drugs [38, 39].
MMP-9 inhibitors (MMPIs) are considered metastasis
deterrents and anti-angiogenic agents for colorectal can-
cer, and have also been proved to inhibit pre-cancerous
states like colitis and other inflammatory bowel diseases
[40]. Although many synthetic MMP inhibitors have
been developed as potential anticancer drugs [40, 41],
because of MMP’s ubiquity, most trials were hampered
by dose-limiting toxicity, insufficient clinical benefits
and lack of specificity. Natural, plant and food-based
MMP9 inhibitors are currently more preferable to these
inhibitors because of their lack of side effects and poten-
tially higher specificity. In the last few years, a different
perspective has emerged suggesting that using crude
and/or standardized extracts as opposed to single com-
pounds might be an advantage since each component
has its major effect when acting synergistically with
other components in the plant [14, 42, 43]. In this con-
text, it also important to refer that there is an overall
lack of consistency concerning the type of extractions to
use. Some reports refer to aqueous extracts [15] whilst
Fig. 5 a Inhibition of gelatinolytic activity by A. arborescens and A. vera extracts. Extracellular HT29 cell media samples were subjected to a non-
reducing gel electrophoresis (SDS-PAGE) in 12,5% /w/v) polyacrylamide gels supplemented with 0.2% (w/v) gelatin from bovine skin, type B. After
renaturation, MMP-2 and MMP-9 activity was stimulated by incubation in reaction buffer (see material and methods) and the gel was stained for
total protein. The presence of gelatinase activities was observed by clear bands against a dark blue background. b Relative activities of MMP-9
and MMP-2 bands calculated as a % of controls. c Gelatinolytic activities of commercial MMP-9 after exposure to Aloe methanolic extracts. MMP-9
was incubated in the presence of A. arborescens or A. vera extracts and its activity was quantified by the DQ-gelatin assay. Results are expressed
as percentage of controls. Values are the mean of at least three replicate experiments ± SD. *p < 0.05, **p < 0.001
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others use alcoholic or organic solvents such as metha-
nol or acetone [16, 17]. Since the main phytochemical
groups range from phenolic compounds to carbohy-
drates, proteins, organic and inorganic compounds as
well as vitamins [3, 33–36], it becomes important to test
different types of extractions to identify, which provide
the highest amount of bioactive compounds, and allows
the better synergy among them. After comparing the an-
ticancer and MMP-9 inhibitory potential of two extracts
from A. vera and A. arborescens, we selected the 50% (v/
v) methanolic extractions for the remaining cancer cell
assays. Interestingly, we also found that both Aloe ex-
tracts similarly reduce HT29 colon cancer cell prolifera-
tion in a dose-dependent manner. According to Lissoni
et al. [44], this result was not surprising, as aloenin and
other analogous molecules may be classified within the
group of anthraquinonic and anthracenic substances,
whose antiproliferative cytotoxic effects are widely
known. Whilst the cell proliferation assay allows the as-
sessment of growth inhibition, cell metabolism and over-
all cytotoxicity, the wound healing assay helps to assess
the reaction of confluent cells in response to a disrup-
tion of cell-cell contacts. What generally occurs is a
growth factors concentration increase at the wound
margins stimulating proliferation and migration in order
to close the opened gap [45], thus mimicking the meta-
static process of cell migration. These two processes are
particularly important when considering cancer develop-
ment and have been associated to MMP activity, mainly
MMP-9. Our results demonstrated significant differences
between Aloe species when colon cancer cell migration
was analysed. In fact, A. vera was less effective in inhibit-
ing cell invasiveness than A. arborescens. Other reports
using different plant extracts with known MMP-9 inhibi-
tory activities [16, 17, 20, 30, 46–48] showed similar re-
sults and a known MMP-9 inhibitor, doxycycline in the
same conditions induced similar reductions in cell migra-
tion [40]. These results suggest that although A. vera is
the most used species and has been attributed numerous
therapeutic benefits, regarding anti-cancer potential, it
may not be as efficient as it has been described in reducing
cancer cell migration. Indeed, even though there are sev-
eral works highlighting the pytochemical composition of
A. vera, much less is known about other species, like A.
arborescens. Nonetheless A. arborescens has been the tar-
get of several studies in the last years, some of which asso-
ciated to its anti-cancer properties [5, 44, 46, 49]. For
example, A. arborescens was already proven to be effective
in aiding chemotherapy when given orally at a dose of 10
mL thrice daily of a mixture consisting of 300 g of fresh
leaves in 500 g of honey plus 40 mL of 40% (v/v) alcohol,
either during or after chemotherapy [44]. This might be
due to its capacity to inhibit tumor invasion and cell mi-
gration [30, 32].
Despite being effective in reducing cell migration, pre-
vious studies have already shown that some plant ex-
tracts, such as persimmon for example, can reduce cell
migration but not through MMP-9 inhibition [47]. We
therefore proceeded to evaluate if there was indeed
MMP enzymatic inhibition.
MMP-2 was the first endopeptidase recognized to de-
grade collagens and to be related to the invasive and
metastatic potential of cancer cells [45]. The active form
of MMP-2 co-localizes with a pro-form of MMP-9 in
various types of cancer, being able to activate it, conse-
quently increasing tumor malignancy [50]. On the other
hand, MMP-9 is linked to the promotion of metastiza-
tion, angiogenesis and cell survival [23]. Since A. vera
has been shown to concomitantly exhibit anti-inflamma-
tory and anti-cancer activities, it appears reasonable to
infer that targeting MMP-9 (a known key player in both
conditions) could be one of Aloe’s biocomponents mode
of action.
However, though there are many reports on the anti-
cancer activities of A. vera, to our knowledge, there are
no studies which correlate its anticancer activities with
MMP-9 and MMP-2 enzymatic activity inhibition in
cancer cells. Similarly, although there has been a consid-
erable body of research associated to the effects of A.
vera on cancer cells, very few use the whole extract, and
even fewer have tested A. arborescens.
Our results demonstrated that both A. vera and A.
arborescens extracts inhibited MMP-9 and MMP-2 en-
zymatic activities, especially towards MMP-9. Since
MMP-9 is strongly associated to inflammation, wound
healing and cancer migration [23, 51, 52], these results
are more consistent to the anecdotal reports on Aloe
bioactivities. A higher MMP-9 enzymatic inhibition can
be of noteworthy importance because it has been consid-
ered that most MMPIs are non-specific, and this is, in
turn, responsible for their generalized adverse side ef-
fects observed in most MMP studies. A more specific ac-
tivity inhibition targeted exclusively to MMP-9,
particularly in colon cancer, where this MMPI might act
in situ, may be of significant potential to anticancer and
anti-inflammatory approaches in the gastrointestinal dis-
eases. Moreover, our results show that the detected in-
hibitory activities were due to direct binding of Aloe
extract components to MMP-9, being this inhibition
higher for A. arborescens than for A. vera. These results
suggest that the higher MMP inhibitory activities in A.
arborescens can be related to the higher inhibition of cell
migration found for this species. Nevertheless, the per-
centage of activity reduction was not as high as the one
observed in the zymographic analysis, where MMP-9’s
activity was reduced more than 50%., suggesting that the
Aloe extracts do not only inhibit directly this enzyme,
but may also use alternative mechanisms. This is in
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agreement with the results obtained by Vijayalakshmi et
al. [23] that showed A. vera extracts down regulating
metalloproteinase expression, specifically MMP-9.
Regardless of having similar concentrations of various
bioactive classes of compounds, A. arborescens seems to
be a more effective cancer cell migration inhibitor than A.
vera. This might be due to a larger concentration and/or
greater number of bioactive compounds like anthraqui-
nones present in A. arborescens, or to the presence of spe-
cific compounds not yet identified in this species. Even so,
results show that in studies related to cancer prevention
or therapy using Aloe species, A. arborescens should be
considered as an effective alternative to A. vera. Addition-
ally, our results also highlight the importance of the ex-
traction procedure to obtain higher amounts of bioactive
extracts, such as anthraquinones, phenolics and polysac-
charides, particularly in A. vera.
Conclusions
Our general results suggest specific important issues: 1)
the genus Aloe is capable of inhibiting MMP-9 and MMP-
2, although more efficiently MMP-9, 2) there are indeed
differences among Aloe species, and 3) A. vera is possibly
not the most efficient Aloe species. These facts allow us to
ask important questions: is all the debate and misconcep-
tion about A. vera being caused by erroneous uses of dif-
ferent species (more or less efficient, or more toxic than
A. vera)? And are we missing out on not testing other Aloe
species, in search for important bioactivities, which can ef-
ficiently be used in medical treatments? Either way, results
here show that when considering the potential of Aloe, it
is extremely important to take into consideration the type
of extraction used, the species of Aloe and also their ef-
fects on individual MMPs.
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